These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 15487854)
1. [Secondary prevention of stroke with antiplatelet drugs]. Diener HC Med Klin (Munich); 2004 Aug; 99 Suppl 1():21-5. PubMed ID: 15487854 [TBL] [Abstract][Full Text] [Related]
2. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial. Serebruany VL; Malinin AI; Pokov AN; Hanley DF Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263 [TBL] [Abstract][Full Text] [Related]
3. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS). Diener HC; Sacco R; Yusuf S; ; Cerebrovasc Dis; 2007; 23(5-6):368-80. PubMed ID: 17337887 [TBL] [Abstract][Full Text] [Related]
5. Antiplatelet agents and randomized trials. Diener HC Rev Neurol Dis; 2007; 4(4):177-83. PubMed ID: 18195669 [TBL] [Abstract][Full Text] [Related]
6. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling? Diener HC Int J Stroke; 2006 Feb; 1(1):4-8. PubMed ID: 18706062 [TBL] [Abstract][Full Text] [Related]
7. From CURE to MATCH: ADP receptor antagonists as the treatment of choice for high-risk atherothrombotic patients. Hacke W Cerebrovasc Dis; 2002; 13 Suppl 1():22-6. PubMed ID: 11803184 [TBL] [Abstract][Full Text] [Related]
9. [The value of platelet inhibitors in the secondary prophylaxis of stroke -- a review]. Schellinger PD; Jüttler E; Meyding-Lamadé UK; Schwark C Fortschr Neurol Psychiatr; 2004 May; 72(5):270-81. PubMed ID: 15136948 [TBL] [Abstract][Full Text] [Related]
10. Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents. Jamieson DG; Parekh A; Ezekowitz MD J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):153-61. PubMed ID: 16211203 [TBL] [Abstract][Full Text] [Related]
11. Antiplatelet therapy in cerebrovascular disease: implications of Management of Artherothrombosis with Clopidogrel in High-risk Patients and the Clopidogrel for High Artherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance studies' results for cardiologists. Fintel DJ Clin Cardiol; 2007 Dec; 30(12):604-14. PubMed ID: 17847044 [TBL] [Abstract][Full Text] [Related]
12. [Secondary prevention with clopidogrel after TIA or stroke]. Zuurbier SM; Vermeer SE; Hilkens PH; Algra A; Roos YB Ned Tijdschr Geneeskd; 2013; 157(25):A5836. PubMed ID: 23777963 [TBL] [Abstract][Full Text] [Related]
14. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy. Biller J J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153 [TBL] [Abstract][Full Text] [Related]
15. [Meta-analysis on the efficacy and adverse events of aspirin plus clopidogrel versus aspirin-monotherapy in patients with ischemic stroke or transient ischemic attack]. Yang C; Qian J; Tang X; Gao P; Hu Y Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Dec; 36(12):1430-5. PubMed ID: 26850406 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of antiplatelet agents for secondary prevention of stroke using mixed treatment comparison meta-analysis. Malloy RJ; Kanaan AO; Silva MA; Donovan JL Clin Ther; 2013 Oct; 35(10):1490-1500.e7. PubMed ID: 24139421 [TBL] [Abstract][Full Text] [Related]
17. Dual antiplatelet therapy with clopidogrel and aspirin for secondary stroke prevention. Wang Y; Chen W; Wang Y Curr Cardiol Rep; 2015 Oct; 17(10):89. PubMed ID: 26294261 [TBL] [Abstract][Full Text] [Related]
19. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected]. Kirshner HS Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660 [TBL] [Abstract][Full Text] [Related]
20. Effect of clopidogrel plus ASA vs. ASA early after TIA and ischaemic stroke: a substudy of the CHARISMA trial. Hankey GJ; Johnston SC; Easton JD; Hacke W; Mas JL; Brennan D; Mak KH; Bhatt DL; Fox KA; Topol EJ; Int J Stroke; 2011 Feb; 6(1):3-9. PubMed ID: 21205234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]